Neogen Corporation
USD9.10
-0.48 (-5.01%)
CEO
Mikhael Nassif
IPO Date
1989-08-23
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$9.50
Prev. Close
$9.58
Day Low
$8.99
Day High
$9.54
52W Low
$4.56
52W High
$11.43
Market Cap
$1.98B
Volume
2.73M
| -302.2 |
| 31 May 2023 | FY | 49.4% | -2.8% | -0.7% | -0.5% | 0.29 | 4.03 | -144.4 |
| 31 May 2022 | FY | 46.1% | 9.2% | 5.4% | 4.9% | 0.00 | 8.05 | 59.0 |
| 31 May 2021 | FY | 45.9% | 13.0% | 7.2% | 6.6% | 0.00 | 11.03 | 79.8 |
| 31 May 2020 | FY | 46.9% | 14.2% | 8.2% | 7.5% | 0.00 | 11.08 | 63.5 |
| 31 May 2019 | FY | 46.3% | 14.5% | 9.4% | 8.6% | 0.00 | 11.75 | 48.6 |
| 31 May 2018 | FY | 46.8% | 15.9% | 11.3% | 10.2% | 0.00 | 9.71 | 62.0 |
| 31 May 2017 | FY | 47.1% | 12.2% | 9.3% | 8.3% | 0.00 | 8.14 | 55.2 |
| 31 May 2016 | FY | 47.6% | 11.4% | 9.0% | 8.1% | 0.00 | 8.74 | 50.7 |
| -20.2 |
| 31 Aug 2025 | Q1 | 34.4% | 17.4% | 1.7% | 1.1% | 0.37 | 3.58 | 8.6 |
| 31 May 2025 | Q4 | 41.2% | -271.5% | -29.6% | -17.8% | 0.44 | 3.32 | -0.5 |
| 28 Feb 2025 | Q3 | 39.4% | -5.0% | -0.4% | -0.3% | 0.34 | 3.91 | -49.8 |
| 30 Nov 2024 | Q2 | 38.8% | -197.3% | -17.1% | -11.3% | 0.33 | 3.77 | -1.7 |
| 31 Aug 2024 | Q1 | 39.8% | -5.8% | -0.4% | -0.3% | 0.28 | 4.41 | -74.1 |
| 31 May 2024 | Q4 | 47.9% | -2.3% | -0.2% | -0.1% | 0.29 | 3.82 | -131.5 |
| 29 Feb 2024 | Q3 | 50.5% | -0.9% | -0.1% | -0.0% | 0.28 | 3.82 | -460.4 |
| 30 Nov 2023 | Q2 | 50.9% | -1.5% | -0.1% | -0.1% | 0.28 | 3.54 | -263.3 |